(firstQuint)A Comparison Study of PF708 and Forteo in Healthy Subjects.

 This is a double-masked, randomized, two-treatment cross-over study in healthy adult subjects.

 Half of the subjects will be randomized to receive PF708 first and Forteo second (Sequence A), and the other half will be randomized to receive the drugs in reverse sequence (Sequence B),.

 A Comparison Study of PF708 and Forteo in Healthy Subjects@highlight

The purpose of this study is to compare the pharmacokinetics (blood levels) of two teriparatide products, PF708 and Forteo, in healthy subjects.

